Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1Phase 1 1

Status

Completed 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 70Triple Negative Breast Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 4Inflammatory Breast Neoplasms 3Seroma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Invasive Breast Cancer 2Carcinoma, Ductal, Breast 2Breast Cancer Invasive 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sarcoma 1Premenopausal Breast Cancer 1Patient Preference 1Pain, Postoperative 1Pain 1Neoplastic Cells, Circulating 1Neoplasms 1Myofibroma 1Mesothelioma, Malignant 1Lymphatic Metastasis 1Inflammation 1Hereditary Breast and Ovarian Cancer Syndrome 1HER2-positive Early Breast Cancer 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

pembrolizumab 163Carboplatin 146Paclitaxel 125Cyclophosphamide 94130-nm albumin-bound paclitaxel 66Capecitabine 64Gemcitabine 54Doxorubicin 50Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 41Cisplatin 39sacituzumab govitecan 34Nivolumab 34olaparib 32Epirubicin 32Specimen Handling 28Docetaxel 28eribulin 27Bevacizumab 26durvalumab 25Drug Therapy 25Biopsy 24camrelizumab 23Magnetic Resonance Spectroscopy 22toripalimab 19Radiotherapy 17spartalizumab 16Everolimus 15veliparib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Surgical Procedures, Operative × Breast × Clear all
NCT04770272 2026-01-12

neoMono

Palleos Healthcare GmbH

Phase 2 Terminated
442 enrolled 42 charts
Breast

Triple Negative Breast Neoplasms

NCT07016399 2025-10-30

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Vanderbilt-Ingram Cancer Center

Phase 2 Recruiting
51 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02620280 2024-03-06

NeoTRIPaPDL1

Fondazione Michelangelo

Phase 3 Completed
278 enrolled
Breast

Carcinoma, Ductal, Breast, Triple Negative Breast Neoplasms

NCT05843292 2023-06-06

NeoSTEP

Shanghai Jiao Tong University School of Medicine

Phase 4 Not yet recruiting
48 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01009437 2017-12-05

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
28 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡